Stem Cells Clinical Trial
Official title:
Isolation and Characterization of Mammary Stem Cells
Background:
- Cancer stem cells in breast cancer have been identified as a small population of tumor
cells whose self-renewal mechanism is highly deregulated. This deregulation seems to be
necessary for cancer to develop.
- These cells can be identified by certain surface markers that overlap with markers
associated with normal embryonic stem cells.
Objective: To isolate tumor stem cells using the same methods generally used to isolate human
embryonic stem cells.
Eligibility:
- Tissue samples will be obtained from the human cooperative network.
- Samples will include normal tissues from individuals who have no opportunistic diseases
and from individuals with cancer.
Design: Breast cancer stem cells will be isolated, grown in the laboratory and characterized.
Cancers are composed of heterogeneous populations of cells with varying degrees of
proliferative capacity and ability to reconstitute tumors when transplanted into nude or SCID
mice.
Recently, cancer stem cells have been identified as a small population of tumor cells which
possess the stem cell properties in that their self-renewal pathway is highly deregulated.
This deregulation seems to be the prerequisite for the development of cancer.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03629015 -
Safety Study of Stemchymal® in Acute Liver Failure
|
Phase 1 | |
Not yet recruiting |
NCT04998461 -
Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells
|
||
Completed |
NCT04132531 -
Effect of Weight Loss Surgery on Stem Cells.
|
||
Completed |
NCT03381599 -
Stem Cells After Peripheral Mobilization and Harvest
|
Phase 1 | |
Completed |
NCT02697682 -
Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study
|
N/A | |
Active, not recruiting |
NCT03874572 -
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
|
Phase 1 | |
Not yet recruiting |
NCT03361631 -
Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes
|
Phase 1 | |
Not yet recruiting |
NCT03983902 -
Placental Transfusion Methods and Stem Cells
|
N/A | |
Completed |
NCT06219161 -
The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.
|
N/A | |
Completed |
NCT04713436 -
The Effects of Antibiotic Combinations on Stem Cells
|
||
Active, not recruiting |
NCT03028428 -
Intra-articular Injection of MSCs in Treatment of Knee OA
|
Phase 2 | |
Recruiting |
NCT04646603 -
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
|
Phase 2 | |
Withdrawn |
NCT02677350 -
AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)
|
Phase 1 | |
Terminated |
NCT00316069 -
Stem Cell Collection
|